<DOC>
	<DOCNO>NCT01563367</DOCNO>
	<brief_summary>The purpose study demonstrate intravenous iron isomaltoside 1000 ( Monofer® ) superior compare placebo respect increase haemoglobin level non-anaemic patient undergo cardiac surgery</brief_summary>
	<brief_title>A Prospective , Comparative Study Intravenous Iron Isomaltoside 1000 ( Monofer® ) Administered Infusions Non-Anaemic Patients Undergoing Elective Sub-Acute Coronary Artery Bypass Graft , Valve Replacement Combination Thereof</brief_title>
	<detailed_description>The role preoperative haemoglobin predictor short-term long-term outcome cardiac surgery well establish . Anaemia impede patient 's ability recover fully participate postoperative rehabilitation . It find patient normal haemoglobin level may become anaemic surgery . An evaluation patient undergoing cardiac surgery , i.e . CABG , valve combine CABG-valve procedure show decrease mean haemoglobin level pre-surgery two four day surgery . To date , prospective randomise clinical study cardiac surgery assess effect intravenous iron supplementation patient undergoing cardiac surgery report . This prospective , randomize , placebo control , double blind study plan evaluate effect intravenous iron isomaltoside 1000 ( Monofer® ) comparison placebo non-anaemic patient undergo cardiac surgery .</detailed_description>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>1 . Men woman , age 18 year . 2 . Subjects undergo elective subacute CABG , valve replacement combination thereof 3 . Female Hb ≥ 12.0 g/dl ( 7.45 mmol/l ) , Male Hb ≥ 13.0 g/dl ( 8.1 mmol/l ) . 4 . Willingness participate inform consent . 1 . Subjects receive blood transfusion le 30 day screen and/or elective subacute CABG , valve replacement , combination thereof . 2 . Iron overload disturbance utilization iron ( e.g . haemochromatosis haemosiderosis ) . 3 . Serum Ferritin &gt; 800 ng/ml . 4 . Known hypersensitivity excipients investigational drug product . 5 . Patients history multiple allergy . 6 . Decompensated liver cirrhosis hepatitis . 7 . Alanine Aminotransferase ( ALT ) &gt; 3 time normal upper value . 8 . Acute infection ( assessed clinical judgement ) . 9 . Rheumatoid arthritis symptom sign active joint inflammation . 10 . Pregnant nursing . ( To avoid pregnancy , woman postmenopausal ( least 12 month must elapse since last menstruation ) , surgically sterile , woman child bear potential must use one follow contraceptive whole study period study end least 5 time plasma biological halflife investigational medicinal product : Contraceptive pill , Intrauterine Devices ( IUD ) , contraceptive depot injection ( prolongedrelease gestagen ) , subdermal implantation , vaginal ring , transdermal patch ) . 11 . Participation clinical trial study drug pass five halflives prior screen . 12 . Untreated Vitamin B12 folate deficiency . 13 . Other IV oral iron treatment within 4 week prior screen visit . 14 . Erythropoietin treatment within 4 week prior screen visit 15 . Impaired renal function define secreatinin &gt; 150 µmol/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Anaemia</keyword>
	<keyword>Cardiac surgery</keyword>
</DOC>